It should be kept in mind that the patient group with s-IL6 levels above the cut-off values may proceed to lymphopenia, hypoalbuminemia, advanced stage, B symptoms, poor performance status, thrombocytosis, elevated LDH, and high mortality. This evidence concerns the gene IL6 and lymphopenia.